Lantos Technologies, Inc, Cambridge, has closed on $1.6 million in a Series A financing. Catalyst Health Ventures led the round, which was joined by additional investors Excel Venture Management and Mass Medical Angels.
Lantos’ novel 3D imaging technology provides minimally invasive digital mapping of the human ear canal, enabling the development of comfortable, custom fit audio devices such as hearing aids, earphones and noise-canceling devices.
“Lantos’ breakthrough imaging technology has the potential to greatly enhance the performance of in-ear communication devices in multiple markets. The technology, which enables precise fitting of hearing devices to the dimensions of the ear canal, promises to provide huge benefits to millions of people suffering from hearing loss, and also opens up new market opportunities in customized user interface for many everyday devices. Catalyst is thrilled to lead this financing and to help bring this exciting product to market,” said Darshana Zaveri, Principal at Catalyst Health Ventures.
“Lantos’ scanner provides important technological improvements that may address multiple markets within the audiology field, including hearing aids, custom earphones, military, hearing protection and related diagnostic applications,” said Rick Blume, Managing Director at Excel Venture Management, in a press release.
Lantos Technologies was previously recipient of an innovation grant from MIT’s Deshpande Center, which provided the initial seed capital for primary research.
SOURCE: Catalyst Health Ventures
